Viewing data from:

ENILLORING

ANDA

ETHINYL ESTRADIOL; ETONOGESTREL | A211157 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: NUVARING(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Enilloring (2023)

Total Spending

$14K

Total Claims

Beneficiaries

Avg Cost/Unit

$104.81

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.015MG/24HR;0.12MG/24HR

0 patents0 exclusivities▴

RING;VAGINAL | Approved: Jun 29, 2023

No patent or exclusivity listings for this strength.